Cargando…

Feasibility of robotic-assisted partial nephrectomy for complete remission of metastatic renal cell carcinoma after long exposure to immune checkpoint inhibitors (UroCCR-106)

Immune checkpoint inhibitors used for metastatic clear cell renal cell carcinoma treatment show significant rates of complete response on metastatic sites. Feasibility of delayed surgery on primitive tumors remains questionable, especially regarding conservative procedures. We present here the first...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mebroukine, Samy, Yacoub, Mokrane, Michiels, Clément, Ravaud, Alain, Gross-Goupil, Marine, Bernhard, Jean-Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731613/ https://www.ncbi.nlm.nih.gov/pubmed/36518643 http://dx.doi.org/10.1093/jscr/rjac560

Ejemplares similares

Comparison of open and robotic-assisted partial nephrectomy approaches using multicentric data (UroCCR-47 study)
por: Ingels, A., et al.
Publicado: (2022)

Positive surgical margin’s impact on short-term oncological prognosis after robot-assisted partial nephrectomy (MARGINS study: UroCCR no 96)
por: Morrone, Arnoult, et al.
Publicado: (2022)

Can Pre-Operative Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Non-Metastatic Renal Carcinoma Recurrence after Nephrectomy? (UroCCR-61 Study)
por: Allenet, Clément, et al.
Publicado: (2022)

A CT-Based Clinical, Radiological and Radiomic Machine Learning Model for Predicting Malignancy of Solid Renal Tumors (UroCCR-75)
por: Garnier, Cassandre, et al.
Publicado: (2023)

External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88)
por: Khene, Zine-Eddine, et al.
Publicado: (2021)

Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study)
por: Margue, Gaelle, et al.
Publicado: (2023)

Management of Immune Checkpoint Inhibitor Toxicities
por: Durrechou, Quentin, et al.
Publicado: (2020)

Tivozanib: is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer?
por: Gross-Goupil, Marine, et al.
Publicado: (2012)

Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?
por: Granet-Vaissiere, Estelle, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers
por: Pichler, Renate
Publicado: (2020)

Axitinib: A Review of its Safety and Efficacy in the Treatment of Adults with Advanced Renal Cell Carcinoma
por: Gross-Goupil, Marine, et al.
Publicado: (2013)

Nefro-Uro /
Publicado: (2018)

Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)
por: Stellato, Marco, et al.
Publicado: (2021)

Adaptation of multidisciplinary meeting decisions in a medical oncology department during the COVID epidemic in a less affected region of France: a prospective analysis from Bordeaux University Hospital
por: Heraudet, Luc, et al.
Publicado: (2020)

Essentials of Uro-Radiology
por: Kabala, J. E.
Publicado: (1991)

Haema-Uro-Chrome
Publicado: (1914)

Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
por: Bersanelli, Melissa, et al.
Publicado: (2021)

Complete remission of renal cell carcinoma with lung carcinomatous lymphangiosis after primary therapy with immune checkpoint inhibitors followed by partial nephrectomy for surgical consolidation
por: Kambe, Takanari, et al.
Publicado: (2022)

Robotics in uro-oncologic surgery
por: De Lorenzis, Elisa, et al.
Publicado: (2013)

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response
por: Teyssonneau, Diego, et al.
Publicado: (2017)

An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
por: Iaxx, Romain, et al.
Publicado: (2022)

Positron emission tomography in uro-oncology
por: Hain, S F
Publicado: (2005)

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study
por: Rebuzzi, Sara Elena, et al.
Publicado: (2022)

Optimal management of renal cell carcinoma in the elderly: a review
por: Quivy, Amandine, et al.
Publicado: (2013)

Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade
por: Larroquette, Mathieu, et al.
Publicado: (2022)

Evaluation of UroVysion for Urachal Carcinoma Detection
por: Hu, Zhiquan, et al.
Publicado: (2020)

Kidney and uro-trauma: WSES-AAST guidelines
por: Coccolini, Federico, et al.
Publicado: (2019)

Renal actinomycosis presenting as uro-cutaneous fistula
por: Diab, Christian, et al.
Publicado: (2019)

Laparoscopic retroperitoneoscopic nephrectomy and partial nephrectomy in children
por: Al-hazmi, Hamdan H., et al.
Publicado: (2015)

Phylogenetic analysis of uroporphyrinogen III synthase (UROS) gene
por: Shaik, Abjal Pasha, et al.
Publicado: (2012)

Use of the Uro Dyna-CT in endourology – the new frontier
por: Vicentini, Fabio C., et al.
Publicado: (2017)

Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
por: Rodler, Severin, et al.
Publicado: (2020)

Adrenal Rests in the Uro-genital Tract of an Adult Population
por: Falco, Enrico Costantino, et al.
Publicado: (2021)

Uro-Genital Tuberculosis: With Especial Consideration of Tuberculosis of the Bladder
por: Lewis, Bransford
Publicado: (1909)

Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience
por: Gonnet, Alexis, et al.
Publicado: (2019)

Multiplex Partial Nephrectomy, Repeat Partial Nephrectomy, and Salvage Partial Nephrectomy Remain the Primary Treatment in Multifocal and Hereditary Kidney Cancer
por: Baiocco, Joseph A., et al.
Publicado: (2017)

What is the role of nephrectomy following complete response to checkpoint inhibitors?
por: Woldu, Solomon L., et al.
Publicado: (2018)

UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study
por: Dodurga, Yavuz, et al.
Publicado: (2013)

Mini-Flank Supra-12th Rib Incision for Open Partial Nephrectomy Compared with Laparoscopic Partial Nephrectomy and Traditional Open Partial Nephrectomy
por: Wang, Hang, et al.
Publicado: (2014)

Management of female uro-genital fistulas: Framing certain guidelines
por: Singh, R. B., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2bb5avm19q78lk0ste4uu65rbo